NanoVibronix Inc.'s subsidiary, ENvue Medical, has announced the launch of its innovative ENvue Drive™ platform, an intelligent robotic system designed to enhance bedside feeding tube and vascular line navigation. This next-generation development aims to automate electromagnetic navigation for enteral and vascular access procedures, addressing the need to increase procedural volume with fewer hands at the bedside. The ENvue Drive™ system integrates with FDA-cleared electromagnetic guidance technology, offering automated alignment and positional stability while allowing clinicians to maintain full control. This strategic initiative builds on ENvue Medical's momentum, including a dual-system acquisition agreement with a major Northeastern U.S. hospital and the issuance of a new U.S. patent for its electromagnetic guidance system for pediatric applications. The company continues to expand geographically across the Southeast, Midwest, and Northeastern U.S., with growing market penetration.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.